Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.03
-0.39-16.12%
Last update: Dec 15, 9:18 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy iBio (IBIO) stock?
You can purchase shares of iBio (NASDAQ:IBIO) through any online brokerage.
Who are iBio (IBIO) competitors?
Other companies in iBio’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Palatin Technologies Inc (AMEX:PTN), ABVC BioPharma Inc (NASDAQ:ABVC), Cue Biopharma Inc (NASDAQ:CUE) and Century Therapeutics Inc (NASDAQ:IPSC).
What is the forecast, or price target, for iBio (IBIO) stock?
iBio has a consensus price target of $4.32.
What is the current price for iBio (IBIO)?
The stock price for iBio (NASDAQ: IBIO) is $2.03 last updated December 15, 2025 at 9:18 AM EST.
Does iBio (IBIO) pay a dividend?
There are no upcoming dividends for iBio.
When is iBio (NASDAQ:IBIO) reporting earnings?
iBio does not have any upcoming earnings scheduled.
Is iBio (IBIO) going to split?
There is no upcoming split for iBio.
What sector and industry does iBio (IBIO) operate in?
iBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
